Remission and time of resolution of nail psoriasis during infliximab therapy [27]

Journal of the American Academy of Dermatology

Volumn 52, Issue 4, 2005, Pages 736-737

  Bianchi, Luca ^a   Bergamin, Antonio ^a   De Felice, Catia ^a   Capriotti, Elisabetta ^a   Chimenti, Sergio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; NAIL DISEASE; NAIL DYSTROPHY; PRIORITY JOURNAL; PSORIASIS; REMISSION;

EID: 17844386820     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.09.012     Document Type: Letter

References (5)

1. E.M. De Jong, B.A. Seegers, M.K. Gulinck, J.B. Boezeman, and P.C. van de Kerkhof Psoriasis of the nail associated with disability in a large number of patients: results of a recent interview with 1,728 patients Dermatology 193 1996 300 303
2. D. De Berker Management of nail psoriasis Clin Exp Dermatol 25 2000 357 362
3. U. Chaudhari, P. Romano, L.D. Mulcahy, L.T. Dooley, D.G. Baker, and A.B. Gottlieb Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial Lancet 357 2001 1842 1847
4. A.B. Gottlieb, S. Masud, R. Ramamurthi, A. Abdulghani, P. Romano, and U. Chaudari Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris J Am Acad Dermatol 48 2003 68 75
5. P. Rich, and R.K. Scher Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis J Am Acad Dermatol 49 2003 206 212